The health care sector ( IYH , XLV ) is outperforming the S&P 500 ( SPY ) through the year's first 11 weeks for the first time in 15 years as companies cut costs and investors bet whatever emanates from D.C. will be good for all involved. "Most of the big drug companies have experienced patent ... iShares U.S. Healthcare ETF ( IYH ) announces quarterly distribution of $0.2962. 12-month yield of 1.55% (as of 02/28/2013). For shareholders of record Mar. 27. Payable Apr. 01. Ex-div date Mar. 25. Post your comment! This health-care ETF levies an expense ratio that's more than double what close rivals charge. This health-care ETF levies an expense ratio that's more than twice what close rivals charges. Healthcare and biotech ETFs continue to churn higher again today, hitting new 52-week highs across the board: Health Care SPDR ( XLV +1% ), Vanguard Health Care ETF ( VHT +0.9% ), iShares Dow Jones US Healthcare ( IYH +0.9% ),. Biotech ETF iShares NASDAQ Biotechnology Index ( IBB +1.3% ). Post your ... Unlike competing health-care ETFs, this mid-cap-tilted ETF underweights Big Pharma in favor of MCOs. This ETF, which offers leveraged daily exposure to health-care stocks, should be kept on a short leash. This targeted ETF invests more than 68% of assets in companies with economic moats. This ETF offers exposure to a broad swath of health-care firms and levies lower fees than those of some rivals. Vanguard's recent expense reduction means 9 of its 10 sector ETFs are now the cheapest available to U.S. investors. With an annual expense ratio of just 0.14%, VOX , VPU , VCR , VDC , VDE , VHT , VIS , VGT , and VAW stack up favorably vs. the 0.18% charged  by State Street's Sector SPDRs ( XLU , ...